La vendita allo scoperto per SelectQuote dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di SelectQuote. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

SelectQuote (NYSE:SLQT) Azioni, Report sulle vendite allo scoperto

SelectQuote

SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

ADBE

CMCM

ORCL

SLQT

Futures USA in calo: SelectQuote, Adobe, Cheetah Mobile, RH e Oracle tra i titoli da seguire oggi in pre-market.

Pre-market: 5 titoli da monitorare oggi, 13 settembre 2024

SelectQuote Inc

Needham analyst James Ricchiuti maintains Kornit Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNT#NASDAQ">KRNT</a>) with a Buy and raises the price target from $27 to $31.

Price Target

Analyst Ratings

KRNT

Needham Maintains Buy on Kornit Digital, Raises Price Target to $31

B of A Securities analyst Julien Dumoulin-Smith maintains TPI Composites (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) with a Buy and lowers the price target from $7 to $4.

TPIC

B of A Securities Maintains Buy on TPI Composites, Lowers Price Target to $4

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Beam Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) with a Buy and maintains $80 price target.

Reiteration

BEAM

HC Wainwright & Co. Reiterates Buy on Beam Therapeutics, Maintains $80 Price Target

B of A Securities analyst Dimple Gosa maintains NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) with a Buy and lowers the price target from $65 to $52.

B of A Securities Maintains Buy on NEXTracker, Lowers Price Target to $52

B of A Securities analyst Julien Dumoulin-Smith maintains Fluence Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) with a Buy and lowers the price target from $25 to $24.

FLNC

B of A Securities Maintains Buy on Fluence Energy, Lowers Price Target to $24

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBT#NASDAQ">CLBT</a>) with a Buy and raises the price target from $17 to $21.

CLBT

Needham Maintains Buy on Cellebrite DI, Raises Price Target to $21

B of A Securities analyst Julien Dumoulin-Smith maintains Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) with a Underperform and lowers the price target from $72 to $62.

ENPH

B of A Securities Maintains Underperform on Enphase Energy, Lowers Price Target to $62

Needham analyst Gil Blum reiterates Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) with a Hold.

FOLD

Needham Reiterates Hold on Amicus Therapeutics

B of A Securities analyst Julien Dumoulin-Smith maintains Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) with a Underperform and lowers the price target from $8 to $7.

B of A Securities Maintains Underperform on Bloom Energy, Lowers Price Target to $7

Piper Sandler analyst Patrick Moley reiterates MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) with a Neutral and maintains $265 price target.

MKTX

Piper Sandler Reiterates Neutral on MarketAxess Holdings, Maintains $265 Price Target

Needham analyst Mike Matson reiterates Surmodics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRDX#NASDAQ">SRDX</a>) with a Hold.

SRDX

Needham Reiterates Hold on Surmodics

Amazon Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) CEO Andy Jassy has expressed his disdain for bureaucracy and announced plans to reduce managerial layers within the company
What Happened: In a company-wide meeting on Tuesday, Jassy outlined the company&#8217;s decision to cut down on&nbsp;the number of managers.
The&nbsp;move was aimed at speeding up decision-making processes and preserving Amazon&#8217;s unique culture, which Jassy believes is being stifled by excessive management layers, <a href="https://www.businessinsider.in/tech/news/in-an-all-hands-meeting-amazon-ceo-andy-jassy-tells-employees-why-he-wants-fewer-managers-i-hate-bureaucracy/articleshow/114996847.cms">reported</a> Business Insider, citing a recording of the meeting.
&#8220;The goal again is to&nbsp;allow us to have higher&nbsp;ownership and to move more&nbsp;quickly,&#8221; Jassy stated during the meeting.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/11/41702294/apple-begins-shifting-iphone-17-production-in-india-cooks-china-optimism-and-more-this-week-in-apple?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple Begins Shifting iPhone 17 Production In India, Cook&#8217;s China Optimism, And More: This Week In Appleverse</a>
Amazon announced in September that it plans to increase the ratio of individual workers to managers by 15% by the end of the first quarter of 2025.
As part of this initiative, Amazon launched a &#8220;Bureaucracy&nbsp;Mailbox&#8221; last month, where employees&nbsp;can voice concerns about unnecessary processes or rules.
 Jassy revealed that over 150 suggestions received through this platform have already been acted upon.
&#8220;The reality is that the&nbsp;S team and I hate&nbsp;bureaucracy,&#8221; Jassy said, referring to&nbsp;Amazon&#8217;s&nbsp;senior leadership team. &#8220;One of the reasons I&#8217;m still at&nbsp;this company is because it&#8217;s&nbsp;not a political or bureaucratic&nbsp;place.&#8221;
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: For the third quarter of 2024, Amazon reported <a href="https://www.benzinga.com/news/earnings/24/10/41664778/amazon-q3-earnings-highlights-revenue-beat-eps-beat-q4-guidance-new-kindles-significantly-outperfor">net sales of $158.9 billion</a>, up 11% year-over-year, beating Street consensus estimates.
Operating income for the third quarter reached $17.4 billion, an increase from $11.2 billion in the same period last year. Amazon Web Services, or AWS, was the primary driver, contributing $10.4 billion in operating income, compared to $7 billion in the third quarter of the previous year.
Amazon has also been expanding its <a href="https://www.benzinga.com/markets/equities/24/11/41735903/meta-amazon-microsoft-partner-on-defense-ai-initiative">partnerships and initiatives</a>, including a collaboration with Meta Platforms Inc., Microsoft Corp., and others on a defense AI initiative.
However, the company has also faced internal challenges. Last month, AWS CEO Matt Garman defended the company's <a href="https://www.benzinga.com/news/24/10/41394784/amazon-aws-ceo-stands-firm-on-5-day-office-policy-opponents-can-head-for-the-exit-door-there-are-oth">contentious new five-day in-office policy</a>, suggesting that those who oppose it may consider other employment options.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41706934/how-to-master-ios-18s-control-center-tips-to-reset-and-customize-your-iphones-quick-access-hub?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">How To Master iOS 18&#8217;s Control Center: Tips To Reset And Customize Your iPhone&#8217;s Quick Access Hub</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Wikimedia

Tech

Media

AMZN

Amazon's Andy Jassy Says 'I Hate Bureaucracy' As He Plans To Slash Managerial Layers: 'The Goal Again Is… To Move More Quickly'

Needham analyst James Ricchiuti reiterates iRobot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>) with a Hold.

IRBT

Needham Reiterates Hold on iRobot

Needham analyst Ryan Koontz reiterates Kaltura (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTR#NASDAQ">KLTR</a>) with a Buy and maintains $3 price target.

KLTR

Needham Reiterates Buy on Kaltura, Maintains $3 Price Target

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) with a Buy and maintains $151 price target.

PRAX

Needham Reiterates Buy on Praxis Precision Medicine, Maintains $151 Price Target

Needham analyst Bernie McTernan maintains Super Group (SGHC) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGHC#NYSE">SGHC</a>) with a Buy and raises the price target from $6 to $7.

SGHC

Needham Maintains Buy on Super Group (SGHC), Raises Price Target to $7

Commodities

Contracts

General

FLNG

Flex LNG Has Agreed With The Charterer Of Flex Courageous And Flex Resolute, A Supermajor, To Amend The Existing Time Charter Agreements For Two LNG Carriers Where The Parties Have Agreed A New Firm Period From 2029 To 2032 Which May Be Extended By An Additional Seven Years In Total Until 2039

Oculis Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCS#NASDAQ">OCS</a>) reported quarterly losses of CHF(0.48) per share which beat the analyst consensus estimate of CHF(0.49) by 2.04 percent.

Earnings Beats

Oculis Holding Q3 2024 Adj. EPS CHF(0.48) Beats CHF(0.49) Estimate, Cash Balance Of CHF105.5M

Piper Sandler analyst Brent Bracelin downgrades HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) from Overweight to Neutral and raises the price target from $570 to $640.

Downgrades

HUBS

Piper Sandler Downgrades HubSpot to Neutral, Raises Price Target to $640

Piper Sandler analyst Brent Bracelin maintains Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) with a Overweight and raises the price target from $13 to $18.

FRSH

Piper Sandler Maintains Overweight on Freshworks, Raises Price Target to $18

Craig-Hallum analyst George Sutton maintained a Buy rating on SelectQuote (SLQT – Research Report) today. The company's shares closed yesterday at ...

SelectQuote (SLQT) Gets a Buy from Craig-Hallum

SelectQuote Q1 Earnings Preview

SelectQuote GAAP EPS of -$0.26, revenue of $292.3M

Sees FY25 Adjusted EBITDA expected in a range of $100M to $130M… Published first on TheFly – the ultimate source for real-time, market-moving break...

SelectQuote sees FY25 revenue  $1.425B$1.525B, consensus $1.44B

Reports Q1 revenue $292.3M, consensus $275.82M.SelectQuote (SLQT) Chief Executive Officer, Tim Danker, remarked, "SelectQuote opened our fiscal 202...

SelectQuote reports Q1 EPS (26c), consensus (18c)

SelectQuote, Inc. 2025 Q1 - Results - Earnings Call Presentation

SelectQuote, Inc. (SLQT) Q1 2025 Earnings Call Transcript

SelectQuote Inc ( ($SLQT) ) has released its Q1 earnings. Here is a breakdown of the information SelectQuote Inc presented to its investors. Select...

SelectQuote Inc. Reports Revenue Growth Amid Losses

Analysts have been eager to weigh in on the Financial sector with new ratings on Northern (NTRS – Research Report) and SelectQuote (SLQT – Research...

Analysts Offer Insights on Financial Companies: Northern (NTRS) and SelectQuote (SLQT)

Craig-Hallum analyst George Sutton upgraded eHealth (EHTH) to Buy from Hold with a price target of $7, up from $5. Results were largely in line wit...

Craig-Hallum says eHealth 'beginning to hit its stride,' upgrades to Buy

EHTH

NTRS

Press Releases

SelectQuote to Release Fiscal Second Quarter 2024 Earnings on February 7

SelectQuote, Inc. Reports Second Quarter 2024 Results

SelectQuote to Release Fiscal Third Quarter 2024 Earnings on May 9; Will Present at RBC's Global Healthcare Conference on May 15

SelectQuote, Inc. Reports Third Quarter 2024 Results

SelectQuote's SelectRx Pharmacy to Open a State-of-the-Art Third Fulfillment Center in Olathe, Kansas, to Support Rapid Growth

SelectQuote to Release Fiscal Fourth Quarter and Full Year 2024 Earnings on September 13

SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2024 Results

SelectQuote Completes First Phase of Recapitalization with $100 Million Securitization

SelectQuote to Release Fiscal First Quarter 2025 Earnings on November 4

SelectQuote, Inc. Reports First Quarter of Fiscal Year 2025 Results

Abacus Life

Arthur J. Gallagher

Aon plc Class A Ordinary Shares (Ireland)

Brown & Brown

The Baldwin Insurance Group, Inc. - Class A Common Stock

Baldwin Insurance

Cheche Group Inc. - Class A Ordinary Shares

Cheche Group

Crawford & Company Common Stock

eHealth

GoHealth

Goosehead Insurance, Inc. - Class A Common Stock

Goosehead Insurance

Hagerty

Hippo Holdings

Huize Holding Limited - American Depositary Shares

Huize Holding

Marsh & McLennan Companies, Inc. Common Stock

Marsh & McLennan

Ryan Specialty Holdings, Inc. Class A Common Stock

Ryan Specialty Hldgs

TIAN RUIXIANG Holdings Ltd - Class A Ordinary Shares

Tian Ruixiang Holdings

TWFG

Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares)

Comments

SelectQuote

Vendite allo scoperto

SelectQuote (NYSE:SLQT) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO